Alexandria Capital’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-43	Closed	-$6K	–	571
2017 Q3	$6K	Buy	43 +37	+617%	+$5.03K	﹤0.01%	449
2017 Q2	$1K	Sell	6 -10	-63%	-$1.16K	﹤0.01%	602
2017 Q1	$2K	Sell	16 -13	-45%	-$1.68K	﹤0.01%	564
2016 Q4	$4K	Sell	29 -59	-67%	-$7.22K	﹤0.01%	507
2016 Q3	$11K	Hold	88	–	–	﹤0.01%	412
2016 Q2	$10K	Buy	88 +1	+1%	+$142	﹤0.01%	415
2016 Q1	$12K	Buy	87 +2	+2%	+$294	﹤0.01%	400
2015 Q4	$16K	Buy	85 +2	+2%	+$349	﹤0.01%	395
2015 Q3	$13K	Buy	83 +4	+5%	+$730	﹤0.01%	380
2015 Q2	$14K	Buy	79 +5	+7%	+$863	﹤0.01%	383
2015 Q1	$13K	Buy	74 +4	+6%	+$724	﹤0.01%	364
2014 Q4	$13K	Hold	70	–	–	0.01%	336
2014 Q3	$12K	Buy	70 +3	+4%	+$493	0.01%	330
2014 Q2	$10K	Sell	67 -3	-4%	-$474	﹤0.01%	359
2014 Q1	$11K	Sell	70 -12	-15%	-$1.91K	﹤0.01%	354
2013 Q4	$11K	Buy	82 +4	+5%	+$480	﹤0.01%	354
2013 Q3	$9K	Sell	78 -7	-8%	-$768	﹤0.01%	379
2013 Q2	$8K	Buy	+85	New	+$8.19K	﹤0.01%	420